Page 80 - AN-4-2

Advanced Neurology Brain bioavailability of targeted protein degraders

doi: 10.1212/wnl.15.1.1 66. Hagenbuch B, Gao B, Meier PJ. Transport of xenobiotics
across the blood-brain barrier. News Physiol Sci. 2002;17:
55. Aird RB. A study of intrathecal, cerebrospinal fluid-to-brain
exchange. Exp Neurol. 1984;86(2):342-358. 231-234.
doi: 10.1016/0014-4886(84)90192-4 doi: 10.1152/nips.01402.2002
56. Pardridge WM. Blood-brain barrier and delivery of protein 67. Löscher W, Potschka H. Blood-brain barrier active efflux
and gene therapeutics to brain. Front Aging Neurosci. transporters: ATP-binding cassette gene family. NeuroRx.
2020;11:373. 2005;2(1):86-98.
doi: 10.3389/fnagi.2019.00373 doi: 10.1602/neurorx.2.1.86
57. Joan Abbott N, Rönnbäck L, Hansson E. Astrocyte- 68. Tsuji A. Small molecular drug transfer across the blood-
endothelial interactions at the blood-brain barrier. Nat Rev brain barrier via carrier-mediated transport systems.
Neurosci. 2006;7(1):41-53. NeuroRx. 2005;2(1):54-62.
doi: 10.1038/nrn1824 doi: 10.1602/neurorx.2.1.54
58. Kandel ER, Koester JD, Mack SH, Siegelbaum SA. Principles 69. Saunders NR, Habgood MD, Møllgård K, Dziegielewska KM.
of Neural Science. New York: McGraw-Hill; 2000. The biological significance of brain barrier mechanisms:
Help or hindrance in drug delivery to the central nervous
59. Hediger MA, Romero MA, Peng JB, Rolfs A, Takanaga H, system? F1000Res. 2016;5:F1000 Faculty Rev-313.
Bruford HA. The ABCs of solute carriers: physiological,
pathological and therapeutic implications of human doi: 10.12688/f1000research.7378.1
membrane transport proteins. Introduction. Pfluegers Arch. 70. Virgintino D, Robertson D, Errede M, et al. Expression
2004;447(5):465-468. of P-glycoprotein in human cerebral cortex microvessels.
doi: 10.1007/s00424-003-1192-y J Histochem Cytochem. 2002;50(12):1671-1676.
60. Eden BD, Rice AJ, Lovett TD, et al. Microwave-assisted doi: 10.1177/002215540205001212
synthesis and in vitro stability of N-benzylamide non- 71. Nies AT. The role of membrane transporters in drug delivery
steroidal anti-inflammatory drug conjugates for CNS to brain tumors. Cancer Lett. 2007;254(1):11-29.
delivery. Bioorg Med Chem Lett. 2019;29(12):1487-1491.
doi: 10.1016/j.canlet.2006.12.023
doi: 10.1016/j.bmcl.2019.04.016
72. Higgins CF, Gottesman MM. Is the multidrug transporter a
61. Wohlrab C, Phillips E, Dachs GU. Vitamin C transporters flippase? Trends Biochem Sci. 1992;17(1):18-21.
in cancer: Current understanding and gaps in knowledge.
Front Oncol. 2017;7:74. doi: 10.1016/0968-0004(92)90419-a
doi: 10.3389/fonc.2017.00074 73. Qosa H, Miller DS, Pasinelli P, Trotti D. Regulation of ABC
efflux transporters at blood-brain barrier in health and
62. Boado RJ, Pardridge WM. The brain-type glucose transporter neurological disorders. Brain Res. 2015;1628:298-316.
mRNA is specifically expressed at the blood-brain barrier.
Biochem Biophys Res Commun. 1990;166(1):174-179. doi: 10.1016/j.brainres.2015.07.005
doi: 10.1016/0006-291x(90)91927-k 74. Shawahna R, Uchida Y, Declèves X, et al. Transcriptomic
and quantitative proteomic analysis of transporters and
63. Farrell CL, Yang J, Pardridge WM. GLUT1 glucose transporter drug metabolizing enzymes in freshly isolated human brain
is present within apical and basolateral membranes of microvessels. Mol Pharm. 2011;8(4):1332-1341.
brain epithelial interfaces and in microvascular endothelia
with and without tight junctions. J Histochem Cytochem. doi: 10.1021/mp200129p
1992;40(2):193-199. 75. Watanabe R, Esaki T, Ohashi R, et al. Development of an
doi: 10.1177/40.2.1552163 in silico prediction model for P-glycoprotein efflux potential
in brain capillary endothelial cells toward the prediction of
64. Covarrubias-Pinto A, Acuña AI, Beltrán FA, Torres-Díaz L, brain penetration. J Med Chem. 2021;64(5):2725-2738.
Castro MA. Old things new view: Ascorbic acid protects
the brain in neurodegenerative disorders. Int J Mol Sci. doi: 10.1021/acs.jmedchem.0c02011
2015;16(12):28194-28217. 76. Li Z, Krippendorff BF, Sharma S, Walz AC, Lavé T, Shah DK.
doi: 10.3390/ijms161226095 Influence of molecular size on tissue distribution of antibody
fragments. MAbs. 2016;8(1):113-119.
65. Vanlandewijck M, He L, Mäe MA, et al. A molecular atlas
of cell types and zonation in the brain vasculature. Nature. doi: 10.1080/19420862.2015.1111497
2018;554(7693):475-480.
77. St-Amour I, Paré I, Alata W, et al. Brain bioavailability of
doi: 10.1038/nature25739 human intravenous immunoglobulin and its transport

Volume 4 Issue 2 (2025) 74 doi: 10.36922/an.5140